These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
451 related articles for article (PubMed ID: 19933193)
1. Neuroprotective effects of intravitreal mesenchymal stem cell transplantation in experimental glaucoma. Johnson TV; Bull ND; Hunt DP; Marina N; Tomarev SI; Martin KR Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):2051-9. PubMed ID: 19933193 [TBL] [Abstract][Full Text] [Related]
2. Neuroprotection of Transplanting Human Umbilical Cord Mesenchymal Stem Cells in a Microbead Induced Ocular Hypertension Rat Model. Ji S; Lin S; Chen J; Huang X; Wei CC; Li Z; Tang S Curr Eye Res; 2018 Jun; 43(6):810-820. PubMed ID: 29505314 [TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effects of intravitreally transplanted adipose tissue and bone marrow-derived mesenchymal stem cells in an experimental ocular hypertension model. Emre E; Yüksel N; Duruksu G; Pirhan D; Subaşi C; Erman G; Karaöz E Cytotherapy; 2015 May; 17(5):543-59. PubMed ID: 25618560 [TBL] [Abstract][Full Text] [Related]
5. Gene therapy with brain-derived neurotrophic factor as a protection: retinal ganglion cells in a rat glaucoma model. Martin KR; Quigley HA; Zack DJ; Levkovitch-Verbin H; Kielczewski J; Valenta D; Baumrind L; Pease ME; Klein RL; Hauswirth WW Invest Ophthalmol Vis Sci; 2003 Oct; 44(10):4357-65. PubMed ID: 14507880 [TBL] [Abstract][Full Text] [Related]
6. Transplanted oligodendrocyte precursor cells reduce neurodegeneration in a model of glaucoma. Bull ND; Irvine KA; Franklin RJ; Martin KR Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4244-53. PubMed ID: 19357352 [TBL] [Abstract][Full Text] [Related]
7. Retinal ganglion cell loss in a rat ocular hypertension model is sectorial and involves early optic nerve axon loss. Soto I; Pease ME; Son JL; Shi X; Quigley HA; Marsh-Armstrong N Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):434-41. PubMed ID: 20811062 [TBL] [Abstract][Full Text] [Related]
8. Translimbal laser photocoagulation to the trabecular meshwork as a model of glaucoma in rats. Levkovitch-Verbin H; Quigley HA; Martin KR; Valenta D; Baumrind LA; Pease ME Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):402-10. PubMed ID: 11818384 [TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stromal cell-mediated neuroprotection and functional preservation of retinal ganglion cells in a rodent model of glaucoma. Mead B; Hill LJ; Blanch RJ; Ward K; Logan A; Berry M; Leadbeater W; Scheven BA Cytotherapy; 2016 Apr; 18(4):487-96. PubMed ID: 26897559 [TBL] [Abstract][Full Text] [Related]
10. Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Promote Neuroprotection in Rodent Models of Glaucoma. Mead B; Amaral J; Tomarev S Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):702-714. PubMed ID: 29392316 [TBL] [Abstract][Full Text] [Related]
11. Protection of retinal ganglion cells and the optic nerve during short-term hyperglycemia in experimental glaucoma. Ebneter A; Chidlow G; Wood JP; Casson RJ Arch Ophthalmol; 2011 Oct; 129(10):1337-44. PubMed ID: 21987677 [TBL] [Abstract][Full Text] [Related]
12. Lack of neuroprotection against experimental glaucoma in c-Jun N-terminal kinase 3 knockout mice. Quigley HA; Cone FE; Gelman SE; Yang Z; Son JL; Oglesby EN; Pease ME; Zack DJ Exp Eye Res; 2011 Apr; 92(4):299-305. PubMed ID: 21272576 [TBL] [Abstract][Full Text] [Related]
13. Intraocular pressure reduction and neuroprotection conferred by bone marrow-derived mesenchymal stem cells in an animal model of glaucoma. Roubeix C; Godefroy D; Mias C; Sapienza A; Riancho L; Degardin J; Fradot V; Ivkovic I; Picaud S; Sennlaub F; Denoyer A; Rostene W; Sahel JA; Parsadaniantz SM; Brignole-Baudouin F; Baudouin C Stem Cell Res Ther; 2015 Sep; 6(1):177. PubMed ID: 26377305 [TBL] [Abstract][Full Text] [Related]
14. Identification of retinal ganglion cell neuroprotection conferred by platelet-derived growth factor through analysis of the mesenchymal stem cell secretome. Johnson TV; DeKorver NW; Levasseur VA; Osborne A; Tassoni A; Lorber B; Heller JP; Villasmil R; Bull ND; Martin KR; Tomarev SI Brain; 2014 Feb; 137(Pt 2):503-19. PubMed ID: 24176979 [TBL] [Abstract][Full Text] [Related]
15. Intravitreally transplanted dental pulp stem cells promote neuroprotection and axon regeneration of retinal ganglion cells after optic nerve injury. Mead B; Logan A; Berry M; Leadbeater W; Scheven BA Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7544-56. PubMed ID: 24150755 [TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of transcription factor Brn3b in an ocular hypertension rat model of glaucoma. Stankowska DL; Minton AZ; Rutledge MA; Mueller BH; Phatak NR; He S; Ma HY; Forster MJ; Yorio T; Krishnamoorthy RR Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):893-907. PubMed ID: 25587060 [TBL] [Abstract][Full Text] [Related]
17. An agonistic TrkB mAb causes sustained TrkB activation, delays RGC death, and protects the retinal structure in optic nerve axotomy and in glaucoma. Bai Y; Xu J; Brahimi F; Zhuo Y; Sarunic MV; Saragovi HU Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4722-31. PubMed ID: 20357199 [TBL] [Abstract][Full Text] [Related]
18. Intravitreal injections of GDNF-loaded biodegradable microspheres are neuroprotective in a rat model of glaucoma. Jiang C; Moore MJ; Zhang X; Klassen H; Langer R; Young M Mol Vis; 2007 Sep; 13():1783-92. PubMed ID: 17960131 [TBL] [Abstract][Full Text] [Related]
19. Expression and activation of mitogen-activated protein kinases in the optic nerve head in a rat model of ocular hypertension. Mammone T; Chidlow G; Casson RJ; Wood JPM Mol Cell Neurosci; 2018 Apr; 88():270-291. PubMed ID: 29408550 [TBL] [Abstract][Full Text] [Related]
20. Lamotrigine monotherapy does not provide protection against the loss of optic nerve axons in a rat model of ocular hypertension. Marina N; Sajic M; Bull ND; Hyatt AJ; Berry D; Smith KJ; Martin KR Exp Eye Res; 2012 Nov; 104():1-6. PubMed ID: 22982756 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]